Source: EIN Presswire

Press Release: LCC : PolarisQB Announces Integration of Virtual Libraries from Liverpool ChiroChem into Quantum-Aided Drug Design

PolarisQB announce integration of Virtual Libraries and Fragmentation schemes from chemical innovator Liverpool ChiroChem into Quantum-Aided Drug Design (QuADD) DURHAM, NORTH CAROLINA, UNITED STATES, August 12, 2024 /⁨EINPresswire.com⁩/ -- Polaris Quantum ...

Read full article »

LCC's Competitors | LCC's News | LCC's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

Co-Founder & CEO

Paul Colbon

CEO Approval Rating

87/100

LCC is an England-based contract research organization that produces and supplies small organic molecules for the biotechnology and pharmaceutical industries.